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Abstract
Background: The molecular mechanisms of dietary oils (such as fish oil) and unsaturated fatty acids, which are
widely used by the public for anti-inflammation and vascular protection, have not been settled yet. In this study,
prostaglandin E2 (PGE2)-mediated calcium signaling was used to screen dietary oils and eight unsaturated fatty
acids for identification of their anti-inflammatory mechanisms. Isolated fat/stromal cells expressing endogenous
PGE2 receptors and an HEK293 cell line specifically expressing the recombinant human PGE2 receptor subtype-1
(EP1) were cultured and used in live cell calcium signaling assays. The different dietary oils and unsaturated fatty
acids were used to affect cell signaling under the specific stimulation of a pathological amount of inflammatory
PGE2.
Results: It was identified that fish oil best inhibited the PGE2 signaling in the primary cultured stromal cells. Second,
docosahexaenoic acid (DHA), found in abundance in fish oil, was identified as a key factor of inhibition of PGE2
signaling. Eicosapentaenoic acid (EPA), another major fatty acid found in fish oil and tested in this study was found
to have small effect on EP1 signaling. The study suggested one of the four PGE2 subtype receptors, EP1 as the key
target for the fish oil and DHA target. These findings were further confirmed by using the recombinant EP1
expressed in HEK293 cells as a target.
Conclusion: This study demonstrated the new mechanism behind the positive effects of dietary fish oils in
inhibiting inflammation originates from the rich concentration of DHA, which can directly inhibit the inflammatory
EP1-mediated PGE2 receptor signaling, and that the inflammatory response stimulated by PGE2 in the fat stromal
cells, which directly related to metabolic diseases, could be down regulated by fish oil and DHA. These findings also
provided direct evidence to support the use of dietary oils and unsaturated fatty acids for protection against heart
disease, pain, and cancer resulted from inflammatory PGE2.
Keywords: Unsaturated fatty acid (UFA), Fish oil, Anti-inflammation, Prostaglandin E2 (PGE2), PGE2 receptor (EP),
EP subtype-1 (EP1)
Background
Fish oil and unsaturated fatty acids (UFAs) are widely
used as supplements for prevention or treatment of in-
flammation, vascular diseases, pain, and cancer; however,
the health benefits and molecular targets of these com-
pounds have not been clearly identified yet.
Nevertheless, many advances have recently been made
by searching the molecular targets of fish oil. It is
believed that the biological activity of fish oil is related
to reducing the excess endogenous prostaglandin E2
(PGE2), which is synthesized through the inducible and
inflammatory cyclooxygenase-2 (COX-2) pathway [1,2].
When cells undergo inflammatory stimulation, an en-
dogenous fatty acid, arachidonic acid (AA), released
from the cell membrane, is converted into an intermedi-
ator, prostaglandin H2, (by COX-2) and then further
converted into PGE2 by PGE2 synthases [3-5]. There are
three different PGE2 synthases in cells that have been
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identified, although the one most associated with inflam-
matory stimulation is the inducible microsomal PGE2
synthase-1 (mPGES-1) [6,7]. The inflammatory activity
of PGE2 is mediated by its receptors (EPs) on the cell
membrane. There are four subtypes of EPs, termed EP1,
EP2, EP3 and EP4 which have been cloned, characterized
[4], and identified in inflammatory tissues and cancers
[8-13]. When the receptors receive excess PGE2, they
immediately begin signaling and cause an increase in
intracellular calcium (by EP1 and EP3) or cAMP (by EP2
and EP4) levels which leads to the biological functions of
PGE2 – thus causing the inflammation that is directly
related to the pathological processes of pain, vascular
diseases, and cancer cell growth [4].
The COX-2/mPGES-1-pathway -induced excess PGE2
signaling plays a key role in inflammation and pain as
confirmed by the non-selective nonsteroidal anti-
inflammatory drugs (NSAIDs) like aspirin and selective
COX-2 inhibitors (Vioxx and Celebrex), which specific-
ally target COX activity [4,5]. From the century old drug,
aspirin [5,14] to the modern COX-2 inhibitor, Celebrex
[5], all NSAIDS have the same goal: inhibit COX’s ability
to reduce excess PGE2 production and signaling. How-
ever, non-selective NSAIDs can cause severe stomach in-
sult, such as bleeding.
In this study, we have screened several dietary oils and
unsaturated fatty acids for identification of the particular
oils and fatty acids with potential use for prevention and
treatment of inflammation and its related diseases. We
found that fish oil and DHA have the ability to inhibit
the inflammatory PGE2 signaling receptor, EP1.
Methods
Materials
Medium for culturing the cell lines was purchased from
Invitrogen. Other reagents were from Sigma. Dietary oils
including olive, sesame, canola, fish oils were obtained
from the Whole Foods brand 365. Unsaturated fatty
acids (ALA, DHA, Erucic acid, EPA, oleic, LA, RA, and
AA), Fluo-8 AM and lipase were obtained from Sigma
(St. Louis, MO).
Cell culture
The mouse stromal cells expressing endogenous subtype
EPs were isolated from mouse fat tissue and cultured
using Dulbecco's Modified Eagle's Medium (DMEM)
medium with fetal bovine serum (FBS) as described pre-
viously [15]. The protocol for the animal fat cell extrac-
tion was approved by the University of Houston
Institutional Animal Care and Use Committee.
EP1 receptor pcDNA construction
A pAcSG-EP cDNA cloned by our laboratory was first
subcloned into EcoRI/XhoI sites of pcDNA3.1 (+)
expression vector to generate the plasmid of pcDNA:
human EP1. The pcDNA vector has a Cytomegalovirus
(CMV) promoter and geneticin (G418) as the selection
antibiotic.
Stable expression of recombinant human EP1 in HEK293
cells
The generation of the HEK293 cell line stably expressing
human EP1 (HEK293-hEP1) has been described previ-
ously [16]. Briefly, HEK293 cells cultured in DMEM
containing FBS (10%), antibiotics, and antimycotics were
transfected with the purified pcDNA: human EP1 using
the Lipofectamine 2000 method [16]. Approximately 48
hours after transfection, the cells were subcultured and
incubated with G418 (selection antibiotic) for four weeks




The cultured cells were collected and washed with PBS.
The proteins were separated by 7-10% (w/v) SDS-PAGE
under denaturing conditions and then transferred to a
nitrocellulose membrane. Bands recognized by individ-
ual primary antibodies were visualized with horseradish
peroxidase-conjugated secondary antibody as described
[16].
Digestion of oils
One milliliter of each oil (olive, canola, sesame, and fish)
was individually mixed with 10mg of lipase in 50 μl of
PBS. The mixtures were vortexed and kept at 37°C for
two hours and then centrifuged at 5,000 revolutions per
minute (rpm) for five minutes. Supernatants were stored
at 4°C.
Determination of PGE2 signaling
The cultured cells were washed twice (1 mL medium/
well), and then incubated with new cell culture medium
(1 mL/well) containing calcium binding reagent, Fluo-8
(50 μg). After 30 minutes of incubation at 37°C, the cells
were washed with serum-free medium three times to re-
move the excess Fluo-8 that did not enter the cells, and
then observed under a Nikon fluorescence microscope
(Nikon, Eclipse Ti) using a software (NIS Elements 2.35)
designed specifically for calcium signaling. To start the
signaling assay, PGE2 (50 μL, 0.12 μM) was added. The
increasing fluorescence signal, generated by the calcium
bound to Fluo-8 inside the cells through the binding of
PGE2 to its receptor, was recorded under the fluores-
cence microscope and analyzed.
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Determination of the effects of the dietary oils on the
PGE2-mediated receptor signaling in the cells
A procedure similar to that used above was performed
for the determination of the effects of the dietary oils on
PGE2-mediated receptor signaling. The only difference
was that the PGE2 used was mixed with the digested in-
dividual oils at varied concentrations for 5 minutes be-
fore being added to the Fluo-8 loaded cells.
Determination of the effects of individual fatty acids on
the PGE2-mediated receptor signaling in the cells
Individual fatty acids dissolved in DMSO (10 μl, 10 μM))
were mixed with the PGE2 for five minutes, and then
added into Fluo-8-loaded cells. The fluorescence
changes were recorded under the fluorescence micro-
scope. The PGE2 mixed with PBS was used as control.
Data analysis
To observe the intensity of the fluorescence signaling
mediated by the PGE2 in the absence and presence of
the dietary oils and fatty acids, the specific effects of the
dietary oils and fatty acids on the PGE2 signaling were
identified by the comparison of the their signal inten-
sities. After analyzing the control cells results, the results
were plotted to show the difference between the oils and
fatty acids. The experiments were repeated three times.
Statistical analysis
Student’s t-test was used as the statistical analysis tool.
Results
The expression of endogenous PGE2 receptors in fat
stromal cells
During inflammation, COX-2 and mPGES-1 genes in
the cells are upregulated, which increase the enzyme
levels to metabolize the endogenous unsaturated fatty
acid, arachidonic acid (AA). AA is converted into a me-
diator (PGH2) by COX-2, and then further converted
into PGE2 by PGES enzymes. This pathway can result in
excess PGE2, which binds to receptors on the surface of
cells. The binding causes the receptor to couple to in-
ternal proteins and trigger an increase in secondary mes-
senger molecules, such as calcium and cAMP inside the
cell. This signaling has been identified as a pathogenic
factor promoting cancer, heart diseases, and arthritis/
pain. The fat stromal cells were isolated from the mouse
fat tissue and cultured. The PGE2 receptors were identi-
fied by Western blot analysis using EP subtype-specific
antibodies (Figure 1). Among the four EPs, EP1and EP3
mediates calcium mobilization, but EP2 and EP4 mediate
cAMP changes. For determination of the live cell signal-
ing, EP1 is the best choice since the calcium mobilization
can be monitored while the cells are still alive (in
culture).
Mimicking the gastrointestinal tract to digest oils
The dietary oils taken into the gastrointestinal tract must
be digested into fatty acids and glycerol, and then
absorbed into the body. To mimic this step, the oils were
incubated with lipase (produced by the pancreas) for
120 minutes at 37°C. The lipase was able to break down
the oils into fatty acid and glycerol, as shown in Figure 2.
Identification of the excessive inflammatory PGE2 induced
EP1 signaling in the fat stromal cells using the highly
sensitive Fluo-8 as a calcium indicator
The micromolar concentration of PGE2 which can cause
inflammation was added to the cells to see the response
Figure 1 Profiles of the Western blot analyses for PGE2
receptors (EPs). 50 μg of the protein of the isolated cultured fat
cells and HEK293 cells over expressing EP1 and control HEK293 cells
were isolated by 12 % PAGE and then transferred to nitrocellulose
membrane. The receptors were stained by specific subtype EP
antibodies, as indicated.
Figure 2 Schematic representation showing the breakdown of
digested oils with lipase. The fatty acid component of the dietary
oil is absorbed into the body through the cell membrane as shown
and then lead to several actions/diseases through the designated
receptor, as indicated.
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through EP1 calcium signaling. However, the traditional
Fura-2 calcium assay for live cells is not sensitive enough
and therefore not very promising for determination of
endogenous EP1 activity. Thus, Fluo-8, one of the newer
calcium indicators was used based on its ability to in-
crease fluorescence signals by 100–250 times when the
compound forms a complex with calcium. Based on this
principle, the membrane permeable Fluo-8 was intro-
duced to the cultured fat stromal cells expressing en-
dogenous EPs. The fluorescent signal increase after the
addition of exogenous PGE2 represents the increase in
intracellular levels of calcium from the inflammatory
PGE2 bound to its receptor (Figure 3). During the assay,
the fluorescence intensity of the live cells was monitored
using the designated fluorescence microscope. The back-
ground signal of the Fluo-8 in the cells is shown in
Figure 3 (before PGE2 addition). After the PGE2 was
added and signaling started, the fluorescence intensity
of the cells increased due to the presence of calcium
signaling induced by the PGE2 bound to its receptors
in the cells. The cell signaling only lasts a few seconds
and then returns to the base line. Figure 3 shows the
individual cells’ response to the calcium signaling after
binding to PGE2.
Determination of the effects of the digested dietary oils
on PGE2-mediated receptor signaling in the live cells
The PGE2 (0.12 μM) was mixed with ~1.0 μl of four in-
dividual, digested dietary oils including fish, olive, canola
and sesame oils, and then was added into the cultured
cells. The profiles of the PGE2-mediated calcium signal-
ing (in the presence of the oils) were recorded and
shown in Figure 4. The data revealed that the only oil
which strongly inhibited PGE2 signaling was fish oil
(Figure 4B, F). Other oils showed interference of the sig-
naling through changes in signaling patterns, but no sig-
nificant inhibition (Figure 4C-E). The significant
Figure 3 Photographs and corresponding fluorescence intensity graphs for individual fat stromal cells before, during, and after PGE2
signaling. Each stromal cell was circled on the screen using a different color to measure their intensity level and the PGE2-induced signaling was
recorded using the corresponding matching colors. The graphs directly below the photographs represent the cell signaling before, during, and
after the addition of PGE2 (0.12 μM). The graph on the bottom is the complete signaling pattern for all cells.
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Figure 4 (See legend on next page.)
Ruan and So BMC Complementary and Alternative Medicine 2012, 12:143 Page 5 of 10
http://www.biomedcentral.com/1472-6882/12/143
inhibition of the fish oil on the PGE2 signaling was fur-
ther compared and plotted in Figure 4F.
PGE2 signaling affected by the different concentrations of
fish oil
To further confirm that fish oil can inhibit PGE2 signal-
ing, increasing concentrations of the digested fish oil
were added to the PGE2 cell signaling system. Figure 5A
showed the entire profiles of PGE2 signaling decreasing
with the increasing digested fish oil concentrations. The
data were further calculated for the peak values, and
then plotted in Figure 5B, which provided a dose re-
sponse curve for identification of 50% inhibition (IC50)
of the oil concentration. The results revealed that 0.02 μl
of the fish oil was able to give approximately 50% inhib-
ition for the PGE2 signaling (Figure 5B). Based on the
estimation that UFAs in the fish oil is approximately
80%, then 0.02 μl of digested fish oil contained approxi-
mately 50% UFAs. Thus, 0.02 μl (18 μg) oil is equivalent
to 9 μg of the mixed UFAs in one mL assay, which gives
approximately a 27 μM concentration based on average
MW 300 for the UFAs.
The effects of individual UFAs on the PGE2-mediated
receptor signaling in the cells
The dietary oils are formed by different unsaturated fatty
acids and glycerol. In order to find out the reasons why
fish oil inhibits PGE2 signaling, eight unsaturated fatty
acids were tested for their inhibition of PGE2 signaling
using the same calcium assay. DHA had the strongest
inhibition of PGE2 signaling (Figure 6). EPA and other
fatty acids did not have significant inhibition at those
concentrations and oleic acid showed 50% inhibition.
Fish oils contain large amounts of DHA and EPA.
Confirmation of the fish oil specifically inhibiting EP1
calcium signaling using recombinant human EP1
expressed in HEK293 cells
To further confirm whether the results obtained from
mouse fat stromal cells could be applied to human use,
a recombinant human EP1 was over expressed in the
human cell line (HEK293) which has minimal expression
of the other subtype EPs, and then used as a target for
the fish oil inhibition assay similar to that described in
Figure 5. Similar results were observed, in which the
digested fish oil has an identical pattern for inhibiting
the human EP1 signaling (Figure 7), which is similar to
that of the fat stromal cells (Figure 5).
Discussion
COX-2 inhibitors can increase the risk for heart disease,
which is a serious side effect because the COX-produced
intermediator, PGH2, is also a substance used for produ-
cing the vascular protective molecule, prostacyclin [5].
Thus, finding supplements as alternatives to the selective
and non-selective NSAIDs to reduce and prevent inflam-
mation is of high importance. Some UFA-rich dietary
oils with unsaturated fatty acids such as fish oil have
been found to have anti-inflammatory functions. Most
reports focused on the observation and confirmation
that dietary oils could reduce PGE2 biosynthesis through
competition with AA on the substrate-binding site of
COXs [17,18]. However, we found that the fish oil was
not very effective in inhibiting COX-2/mPGES-1 activ-
ities via inhibition of the inflammatory PGE2 biosyn-
thesis, and thus may be doing so through another
mechanism. Based on the fact that PGE2 is derived from
a UFA, and that UFA molecules have similar structures
to PGE2, we can safely say that molecules which have
similar structures to PGE2 may bind to some target
molecules, such as EPs, and in turn block PGE2 signal-
ing. In this case, the similar UFA molecules may act as
antagonists against inflammation. Many drugs have been
developed for treatment of diseases based on the antag-
onist principle. The search for an “antagonist” to com-
pete with PGE2 in binding to the receptor and block its
signaling is an important step towards finding something
that can reduce PGE2, yet maintain COX activity for
production of the vascular protector, prostacyclin. This
information has led us to hypothesize that if dietary oils
contain unsaturated fatty acids with similar structures to
that of PGE2, then fish oil and certain omega-3 fatty
acids may have the ability to block PGE2 from binding
to its receptors and then inhibit signaling, resulting in
reduced inflammation. In this paper, we tested this hy-
pothesis and found a novel mechanism of dietary oils
and UFAs showing anti-inflammatory potential through
inhibiting EP signaling. The study has provided import-
ant evidence that fish oil and one of its major ingredi-
ents, DHA, have the ability to inhibit PGE2 signaling,
which highlights the benefit of taking fish oil as a sup-
plement for health, including preventing inflammation,
cancers and heart diseases.
(See figure on previous page.)
Figure 4 Profiles of the inhibition of the oils on PGE2 signaling. Following the same procedures as those mentioned in Fig. 3, the PGE2
signaling was recorded for stromal cells in the presence of PGE2 with buffer (A.), fish oil (B.), olive oil (C.), canola oil (C.), or sesame oil (E.). The
arrow indicates the addition of PGE2 plus buffer/oil. Comparison of the inhibition of the oils on PGE2 signaling (n = 4) was showed in F (1, buffer;
2, fish oil; 3, olive oil; 4, canola oil; 5, sesame oil, and 6, HEK293 control).
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Many studies have shown that the use of UFAs, such
as omega-3 fat acid and the UFA-rich dietary oils, can
benefit in the prevention and reduction of inflammation
that is involved in promoting heart disease, cancer, arth-
ritis, and pain. However, little information is available
regarding the effects of the dietary oils and UFAs on
specific inflammatory PGE2 signaling (mediated by
receptors) that are considered better targets for develop-
ing novel therapeutic interventions against inflamma-
tion. Our study has found that fish oil has a significant
effect on inhibition of PGE2 binding to the EP1 receptor
and thus inhibiting the signaling (Figure 5). The obser-
vation was further confirmed by a dose response assay,
in which the IC50 was established (Figure 6). These
results suggested that the fish oil could also likely bind
to the other subtype PGE2 receptors, EP2, EP 3 and EP 4
and inhibit their signaling. This led to the conclusion
that dietary fish oil can reduce PGE2-mediated inflam-
mation. Therefore, consuming fish oil can reduce major
risk factors of cancers, heart disease, arthritis, and pain.
In contrast, olive oil, canola oil and sesame oil have
altered PGE2 signaling patterns (delaying or prolonging
signaling, Figure 5), but have less effects on inhibition of
PGE2-mediated calcium signaling. Thus, taking these oils
may not yield results as strong as fish oil for the preven-
tion of cancers, heart disease, arthritis, and pain caused
by excess inflammatory PGE2.
To further identify the active ingredient in the fish oil
involved in the inhibition of PGE2 binding to its recep-
tors, screenings of the inhibitory activities of the UFAs
(major ingredients in the dietary oils) were performed.
Among the eight UFAs present in the dietary oils, DHA
best inhibits PGE2-signaling. Data analysis has deter-
mined that fish oil contains high concentrations of DHA
compounds, which provides strong scientific evidence
supporting the study in which fish oil has superior in-
flammation inhibiting abilities. Previously, researchers
had found that fish oil high in DHA and low in EPA
reduced inflammation, but were unaware of the mechan-
isms behind this conclusion [17,18]. This study has pro-
vided a novel finding and evidence that fish oil and
DHA have anti-inflammatory effects through inhibiting
PGE2 receptor signaling.
The study not only provided the mechanism behind
fish oil and DHA acting on receptor levels, but also
quantitatively measured the effect of the fish oil on inhi-
biting PGE2 signaling, which provides important infor-
mation on how to effectively supplement with fish oil. In
Figure 6B, the IC50 for fish oil is about 0.02 μl
(0.018 mg) in a total of 1000 μl (1.0 ml) cell solution.
Thus, the IC50 for fish oil is approximately 18 mg/L or
54 μM (using the average molecular weight of fatty acids
with 300 Daltons). There are 4–5 liters of bloods in a
150 pound body. This means that consuming 100 mg
fish oil should yield IC50 results. If given 5 to 10 times
the IC50, then taking 500 –1000 mg fish oil daily is
recommended based on the findings in this study.
Conclusion
Finally, we conclude that fish oil is a promising dietary
oil used to prevent and reduce inflammation-mediated
diseases, such as heart diseases, cancers, arthritis, and
pain. The mechanism behind the benefits of fish oil is
not only to interfere with PGE2 biosynthesis as reported
previously, but more importantly the fish oil has the
ability to inhibit the inflammatory factor, PGE2 binding
to its receptor and thereby reduce the inflammatory sig-
naling. In other words, fish oil can be taken by people
striving to reduce risks of heart disease, cancer, and arth-
ritis. This study also revealed that the mechanism behind
the inhibiting of PGE2 signaling of fish oils comes from
the rich concentrations of DHA, which have the ability
to directly inhibit PGE2 signaling. These findings may
greatly affect people that consume dietary oils on a daily
basis, and also those concerned with protecting them-
selves against health risks, cancer and pain. This study
was an attempt to find a novel mechanism for the fish
oil and UFA on inhibition of the inflammation. However,
(See figure on previous page.)
Figure 5 A) Profiles for increasing PGE2 signaling inhibition. Increasing amounts of fish oil (as labeled) were added to the stromal cells and
the signaling was recorded. B). Dose response curve for increasing PGE2 signaling inhibition in the stromal cells with fish oil. The IC50
determination by converting Figure 4A inhibition peaks into curve and using approximately 0.02 ul of the fish oil was indicated.
Figure 6 Comparison of the effects of the UFAs on PGE2
signaling through the binding to the EP1 receptor. The intensity
is plotted as percentage (n = 3). The P values of DHA and EPA
compared to others are <0.01 and <0.05, respectively.
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Figure 7 Profiles for increasing PGE2 signaling inhibition. Increasing amounts of fish oil were added to the HEK293-EP1 cells following the
same procedures described in Figure 5 and the signaling was recorded. The HEK293 cell stably expressing recombinant human EP1 receptor was
cultured and used as target to replace the fat stromal cells shown in Figure 5.
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it should be noted that other possibilities and pathways
should not be excluded.
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